Choose Your News
Daiwa has downgraded Chinese e-commerce player Vipshop (VIPS) from Buy to Hold, forecasting around 10% downside to the stock. The broker reduced its price target... [Read More]
VIX ETPs climbed more than 16% as Gary Cohn's job status and a terror attack in Barcelona rocked the market. Airline stocks plunged 3%. [Read More]
Credit card delinquencies are on the rise again, and that could make banks less willing to lend. [Read More]
CenturyLink was the worst-performing stock in the S&P 500 today. [Read More]
Shares of Applied Materials, the biggest vendor of tools to make semiconductors, jumped 4% in late trading after the company beat quarterly revenue and profit... [Read More]
Bill Ackman's Pershing Square laid out its proposal for unlocking shareholder value at ADP. [Read More]
Tom Siebel, who was employee number 20 at Oracle and later sold his company to Larry Ellison for billions, has a new startup that is... [Read More]
Stocks are tumbling today amid worries that the Republican pro-growth agenda could be at risk, and a terrorist attack in Barcelona. [Read More]
Since delivering estimate-beating second quarter earnings on Aug. 3, Allergan's share price has fallen 10%. This analyst offers up a few reasons for the drop. [Read More]
The S&P 500 is near record highs, but millennials are by and large staying out of the stock market. We step into Times Square to... [Read More]
Legg Mason (LM) and T. Rowe Price (TROW) shares are down so far Thursday like everything else. Legg Mason's stock is down more than 2%... [Read More]
Despite NetApp seeing improved sales of newer flash memory-based storage products, analysts still worry about the threat of Dell and EMC, and newcomers such as... [Read More]
Apple's not the rabble-rouser it was 30 years ago. Executives will have to decide whether the brand should be associated with controversial content. [Read More]
Transocean is sliding for a third day following a big acquisition. [Read More]
A technical analyst breaks down the signs. [Read More]
A rival diabetes drug bested Eli Lilly's top growth driver in a recent clinical trial. What does this mean for the U.S. pharmaceutical giant. [Read More]
Foot Locker reports earnings tomorrow morning. Is all the bad news already priced into the stock? [Read More]
Startup Atomera has had a rough ride since coming public last year, but it's novel technology to improve semiconductors bears watching. By inserting a film... [Read More]
Morgan Stanley issued a "double upgrade" on Molina Healthcare, lifting its rating from an Underweight to an Overweight in one fell swoop. [Read More]
Shares of L Brands are plunging today after the company cut its full-year profit forecast. Here's why this analyst sees more problems ahead. [Read More]